pfizer biontech - Search News

News

Pfizer, Q2 and Consensus Estimate

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost cuts.

Houston Chronicle · 7h

Pfizer: Q2 Earnings Snapshot

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.

Zacks.com on MSN · 5h

Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates

Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items.

Pfizer Raises Profit Outlook

Reuters on MSN · 6h

Pfizer raises 2025 profit forecast on cost cuts, forex gains

Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as it expects to benefit from its cost-cutting efforts and a weaker dollar. The

Wall Street Journal · 44m

Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

MarketWatch on MSN · 3h

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

22h

UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

4don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

BioSpace1d

BioNTech Commits to Infectious Diseases Amid Questions Over Vaccine Demand

The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...

1don MSN

BioNTech posts Q2 beat as revenue more than doubles

BioNTech (BNTX) stock gains as the company surpasses Q2 2025 forecasts with 103% YoY revenue growth, thanks mainly to Pfizer ...

The Manila Times on MSN3d

Pfizer and BioNTech lose UK court appeal over Covid-19 jab

Pfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...

BioSpace4d

Moderna Wins UK Patent Battle Against Pfizer and BioNTech

A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.

TheHealthSite on MSN15d

Pfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?

BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

4don MSN

Pfizer/BioNTech lose appeal to reverse Moderna’s COVID vaccine patent win in U.K.

London's Court of Appeal on Friday struck down a case filed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), in a bid to ...

Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results